303 related articles for article (PubMed ID: 36768871)
1. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
[TBL] [Abstract][Full Text] [Related]
2. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
[TBL] [Abstract][Full Text] [Related]
3. McCune-Albright syndrome.
Dumitrescu CE; Collins MT
Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
[TBL] [Abstract][Full Text] [Related]
4. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.
Trojani MC; Gensburger D; Bagouet F; Cortet B; Couture G; Marcelli C; Mehsen Cetre N; Breuil V; Chapurlat R
Bone; 2023 Sep; 174():116819. PubMed ID: 37301527
[TBL] [Abstract][Full Text] [Related]
5. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
[TBL] [Abstract][Full Text] [Related]
6. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
Völkl TM; Dörr HG
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
Majoor BC; Appelman-Dijkstra NM; Fiocco M; van de Sande MA; Dijkstra PS; Hamdy NA
J Bone Miner Res; 2017 Feb; 32(2):264-276. PubMed ID: 27649526
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
[TBL] [Abstract][Full Text] [Related]
9. Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates.
Pan KS; Taylor J; Szymczuk V; Boyce AM
J Bone Miner Res; 2023 Oct; 38(10):1465-1471. PubMed ID: 37477421
[TBL] [Abstract][Full Text] [Related]
10. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Robinson C; Collins MT; Boyce AM
Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
[TBL] [Abstract][Full Text] [Related]
11. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.
van der Bruggen W; Vriens D; Meier ME; Smit F; Winter EM; de Geus-Oei LF; Appelman-Dijkstra NM
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2980-e2994. PubMed ID: 33788944
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features of Chilean patients with Fibrous Dysplasia/McCune-Albright Syndrome].
Jiménez C; Schneider P; Baudrand R; García H; Martínez A; Mendoza C; Grob F; Seiltgens C; Florenzano P
Rev Med Chil; 2022 Oct; 150(10):1275-1282. PubMed ID: 37358085
[TBL] [Abstract][Full Text] [Related]
13. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
[TBL] [Abstract][Full Text] [Related]
14. Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
Bhadada SK; Bhansali A; Das S; Singh R; Sen R; Agarwal A; Mittal BR; Nahar U; Dutta P; Khandelwal N
Indian J Med Res; 2011 May; 133(5):504-9. PubMed ID: 21623035
[TBL] [Abstract][Full Text] [Related]
15. Hyperthyroidism in McCune-Albright Syndrome - a case report.
Rosinha P; Ramalho D; Rodrigues O; Sousa S; Alves C; Lopes J; Caetano JS; Mirante A
J Pediatr Endocrinol Metab; 2023 Mar; 36(3):319-322. PubMed ID: 36351197
[TBL] [Abstract][Full Text] [Related]
16. Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.
Salpea P; Stratakis CA
Mol Cell Endocrinol; 2014 Apr; 386(1-2):85-91. PubMed ID: 24012779
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
[TBL] [Abstract][Full Text] [Related]
18. Brain and eye involvement in McCune-Albright Syndrome: clinical and translational insights.
Mascioli I; Iapadre G; Ingrosso D; Donato GD; Giannini C; Salpietro V; Chiarelli F; Farello G
Front Endocrinol (Lausanne); 2023; 14():1092252. PubMed ID: 37274327
[TBL] [Abstract][Full Text] [Related]
19. Hypothyroidism in McCune-Albright Syndrome and Role of Bone Scan in Management of Fibrous Dysplasia: An Unusual Case Scenario with Review of Literature.
Kumar N; Kheruka SC; Singh RK; Ravina M; Dutta D; Gambhir S
Indian J Nucl Med; 2017; 32(1):25-29. PubMed ID: 28242980
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
